N-Acetylcytidine

Catalog No. :
ACCDYG846
CAS No. :
3768-18-1
Molecular Formula :
C11H15N3O6
Molecular Weight :
285.26

IUPAC Name:N-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide

N-Acetylcytidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$80.00Login to see priceIn stockInquiry
500g97%$399.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Acetylcytidine
IUPAC NameN-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide
MDL No.MFCD00006540
Molecular FormulaC11H15N3O6
Molecular Weight285.26
SMILESCC(NC(C=CN1[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)=NC1=O)=O
InChI KeyNIDVTARKFBZMOT-PEBGCTIMSA-N
SynonymN-Acetylcytidine | n-acetyl-Cytidine | EINECS 223-195-6 | HY-W019670 | N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}acetamide | 4-N-acetyl-cytidine | C22293 | N4 -Acetylcytidine | AKOS015896940 | N-(1-((2
CAS No.3768-18-1
PubChem CID107461

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACCDYG846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCDYG846 route product structure diagram
    ACCDYG8463768-18-1 In Stock
Inquiry

2. ACCDYG846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACCDYG846 route product structure diagram
    ACCDYG8463768-18-1 In Stock
Inquiry

Comments (0)